• Explore /
  • Poster
  • / Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.

Abstract Poster

Authors

null

Robert L. Ferris

Hillman Cancer Center, Pittsburgh, PA

Robert L. Ferris , Yael Flamand , Harry Quon , Gregory S. Weinstein , Ranee Mehra , Joaquin J. Garcia , Seungwon Kim , Bert W. O'malley Jr., Enver Ozer , Giovana R. Thomas , Wayne Koch , Michael Elliot Kupferman , Richard Bryan Bell , Mihir Patel , Miriam Lango , Barbara Burtness

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT01898494

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6036)

DOI

10.1200/JCO.2023.41.16_suppl.6036

Abstract #

6036

Poster Bd #

28

Abstract Disclosures

Similar Posters

First Author: Ranee Mehra

Poster

2023 ASCO Annual Meeting

Association of HPV genotype and phylogenic clade with oropharyngeal cancer outcomes.

Association of HPV genotype and phylogenic clade with oropharyngeal cancer outcomes.

First Author: Michael Wotman

First Author: Marlen Haderlein

First Author: Shengjin Dou